Detalles de la búsqueda
1.
Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX.
Breast Cancer Res;
14(6): R143, 2012 Nov 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-23127292
2.
[Breast cancer and obesity, a dangerous relation]. / Cancer du sein et obésité, une liaison dangereuse.
Rev Med Suisse;
8(342): 1101-4, 2012 May 23.
Artículo
en Francés
| MEDLINE | ID: mdl-22734178
3.
Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy.
Breast Cancer Res Treat;
121(1): 211-8, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19280340
4.
Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century.
Breast Cancer Res Treat;
117(2): 319-24, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19137426
5.
Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93.
Breast Cancer Res Treat;
113(1): 137-44, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18259856
6.
Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93.
Breast Cancer Res Treat;
116(3): 491-500, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-18953651
7.
Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial.
Lancet Oncol;
9(1): 23-8, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18083065
8.
A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.
N Engl J Med;
353(26): 2747-57, 2005 Dec 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-16382061
9.
A randomized clinical trial of adjuvant chemotherapy for radically resected locoregional relapse of breast cancer: IBCSG 27-02, BIG 1-02, and NSABP B-37.
Clin Breast Cancer;
8(3): 287-92, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18650162
10.
Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from International Breast Cancer Study Group Trials V and VI.
Eur J Cancer;
43(11): 1646-53, 2007 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17512721
11.
Estrogen receptor modulators and down regulators: optimal use in postmenopausal women with breast cancer.
Drugs;
67(16): 2335-53, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17983255
12.
Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: long-term observations from International Breast Cancer Study Group Trial VI.
J Clin Oncol;
23(28): 7089-97, 2005 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16192592
13.
Site of primary tumor has a prognostic role in operable breast cancer: the international breast cancer study group experience.
J Clin Oncol;
23(7): 1390-400, 2005 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15735115
14.
Relation between chemotherapy dose, oestrogen receptor expression, and body-mass index.
Lancet;
366(9491): 1108-10, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-16182899
15.
Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IV.
J Clin Oncol;
21(24): 4517-23, 2003 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-14673038
16.
Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer.
J Clin Oncol;
20(7): 1759-66, 2002 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-11919232
17.
The choice of systemic adjuvant therapy in receptor-positive early breast cancer.
Eur J Cancer;
41(3): 357-64, 2005 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-15691634
18.
Adjuvant endocrine therapies for postmenopausal women with early breast cancer: standards and not.
Breast;
14(6): 555-63, 2005 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-16188442
19.
Adjuvant endocrine therapy for the very young patients.
Breast;
12(6): 509-15, 2003 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-14659128
20.
Patterns of Recurrence and outcome according to breast cancer subtypes in lymph node-negative disease: results from international breast cancer study group trials VIII and IX.
J Clin Oncol;
31(25): 3083-90, 2013 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23897954